MASAŘÍK, Michal, Jiří SOCHOR, Branislav RUTTKAY-NEDECKY, Soňa KŘÍŽKOVÁ, Marie STIBOROVÁ, Tomáš ECKSCHLAGER, Vojtěch ADAM and René KIZEK. A determination of oxidative stress in tumour cells treated with cytostatics. In 15th International Symposium on Molecular Medicine. 2012. ISSN 1107-3756.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A determination of oxidative stress in tumour cells treated with cytostatics
Authors MASAŘÍK, Michal, Jiří SOCHOR, Branislav RUTTKAY-NEDECKY, Soňa KŘÍŽKOVÁ, Marie STIBOROVÁ, Tomáš ECKSCHLAGER, Vojtěch ADAM and René KIZEK.
Edition 15th International Symposium on Molecular Medicine, 2012.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 10600 1.6 Biological sciences
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.957
Organization unit Faculty of Medicine
ISSN 1107-3756
UT WoS 000310651600169
Keywords in English oxidative stress; carboplatin; cisplatin; oxaliplatin; doxorubicin; ellipticine; FRAP; DPPH; ABTS; tumour cell lines
Changed by Changed by: Mgr. Martina Raudenská, Ph.D., učo 42700. Changed: 17/10/2012 11:29.
Abstract
Oxidative stress as a response to anticancer drugs is not sufficiently investigated and direct measurement of reactive oxygen species and oxidative stress markers in clinical medicine is still difficult. In our study, oxidative status was studied in model tumour cell lines derived from tumours of the prostate (PC-3, PNT1A, 22RV1). Cell lines were cultured with anticancer drugs carboplatin, cisplatin, oxaliplatin at concentrations of 0, 10, 30 , 50, 80, 100, 150, 180, 200 and 250 micromol/l and drugs as doxorubicin and ellipticine at concentrations of 0, 0.5, 1, 1.5, 2, 4, 6, 10, 12, 15 micromol/l. The rate of oxidative stress was determined by antioxidant activity (FRAP, DPPH and ABTS). Based on the results obtained from oxidative changes in the cells determined by FRAP and ABTS, it was found the lowest antioxidant activity as 0.06 mg of Trolox/l was in cell lines 22RV1 treated with carboplatin at a concentration of 100 micromol/l. PNT1A cells gave the lowest antioxidant activity of 0.35 mg of Trolox/l after exposure to cisplatin concentration of 100 micromol/l.
PrintDisplayed: 29/7/2024 22:03